V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003515 | 280002621 | null | null | Adjuvant (A) | null | 2015-08-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025678 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003516 | 280002622 | 1.7 | 0 | Neo-adjuvant (N) | 2017-11-12 | 2017-11-12 | CISPLATIN + FLUOROURACIL | 02 | null | 280025679 | CISPLATIN + FLUOROURACIL |
| 280003517 | 280002623 | 1.55 | 64 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025681 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003518 | 280002624 | 1.63 | 103.7 | Curative (C) | null | 2015-05-12 | Cetuximab + Radiotherapy Load | N | N | 280025682 | CETUXIMAB + RT |
| 280003519 | 280002625 | null | 50.5 | null | null | 2015-02-20 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025684 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003520 | 280002626 | null | null | null | 2015-03-16 | 2015-03-17 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025686 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003521 | 280002627 | 1.65 | 118.1 | Adjuvant (A) | 2014-08-03 | 2014-08-03 | Doxorubicin + Ifosfamide | N | N | 280025689 | DOXORUBICIN + IFOSFAMIDE |
| 280003522 | 280002628 | null | null | Palliative (P) | 2016-02-25 | 2016-04-07 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025694 | CISPLATIN + FLUOROURACIL |
| 280003523 | 280002629 | 1.68 | 92.7 | Palliative (P) | 2017-07-04 | 2017-07-20 | Doxorubicin + Ifosfamide | N | N | 280025695 | DOXORUBICIN + IFOSFAMIDE |
| 280003524 | 280002629 | null | null | Curative (C) | 2003-01-03 | 2017-04-11 | CETUXIMAB + RT | N | Y | 280025695 | CETUXIMAB + RT |
| 280003525 | 280002629 | null | null | Neo-adjuvant (N) | null | 2018-01-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025695 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003526 | 280002630 | 1.79 | 76.1 | Curative (C) | 2013-05-25 | 2013-06-08 | CETUXIMAB + RT | 2 | N | 280025701 | CETUXIMAB + RT |
| 280003527 | 280002630 | 1.7 | 77 | Curative (C) | 2015-01-04 | 2015-01-12 | CETUXIMAB + RT | 02 | null | 280025701 | CETUXIMAB + RT |
| 280003528 | 280002631 | 1.83 | 98 | Palliative (P) | 2017-12-03 | 2018-01-24 | CETUXIMAB + RT | 2 | N | 280025704 | CETUXIMAB + RT |
| 280003529 | 280002632 | 1.76 | null | Neo-adjuvant (N) | 2018-01-17 | 2018-01-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025706 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003530 | 280002632 | 1.72 | 108 | null | 2014-11-17 | 2014-11-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025706 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003531 | 280002632 | null | null | Neo-adjuvant (N) | 2014-01-22 | 2014-02-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025706 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003532 | 280002633 | 1.52 | 66.8 | Neo-adjuvant (N) | 2014-10-07 | 2014-10-07 | Doxorubicin + Ifosfamide | null | null | 280025709 | DOXORUBICIN + IFOSFAMIDE |
| 280003533 | 280002634 | 1.83 | 68.4 | Curative (C) | 2014-09-02 | 2014-09-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025711 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003534 | 280002635 | 1.79 | 56.6 | Adjuvant (A) | 2014-12-06 | 2014-12-07 | Doxorubicin + Ifosfamide | null | null | 280025713 | DOXORUBICIN + IFOSFAMIDE |
| 280003535 | 280002635 | 1.53 | null | Neo-adjuvant (N) | 2015-10-27 | 2015-10-27 | Doxorubicin + Ifosfamide | N | null | 280025713 | DOXORUBICIN + IFOSFAMIDE |
| 280003536 | 280002635 | 1.61 | null | Curative (C) | null | 2015-08-15 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025713 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003537 | 280002635 | 1.64 | 61.6 | Curative (C) | null | 2015-06-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025713 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003538 | 280002635 | 1.71 | 75.6 | Neo-adjuvant (N) | 2015-09-08 | 2015-09-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025713 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003539 | 280011816 | 1.47 | 86.8 | null | 2015-09-10 | 2015-09-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025723 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003540 | 280002636 | 1.65 | 74 | Neo-adjuvant (N) | 2013-08-16 | 2013-10-11 | CISPLATIN + FLUOROURACIL | N | N | 280025726 | CISPLATIN + FLUOROURACIL |
| 280003541 | 280002636 | 1.63 | 74 | Neo-adjuvant (N) | 2017-11-25 | 2017-12-29 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025726 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003542 | 280002637 | 1.71 | 53 | Adjuvant (A) | null | 2014-11-05 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025730 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003543 | 280002638 | 1.62 | null | Neo-adjuvant (N) | 2016-07-11 | 2016-07-17 | Cisplatin + Docetaxel +Fluorouracil | 99 | N | 280025734 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003544 | 280002639 | 1.79 | 90.5 | Curative (C) | 2014-01-26 | 2014-02-14 | Cetuximab + Radiotherapy Load | N | Y | 280025736 | CETUXIMAB + RT |
| 280003545 | 280002640 | 1.67 | 65.2 | Curative (C) | 2013-12-31 | 2013-12-31 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025737 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003546 | 280002641 | 1.52 | 73.7 | Neo-adjuvant (N) | null | 2016-04-08 | CISPLATIN + FLUOROURACIL | N | N | 280025738 | CISPLATIN + FLUOROURACIL |
| 280003547 | 280007327 | 1.63 | 76.2 | Neo-adjuvant (N) | 2013-11-27 | 2013-12-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025740 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003548 | 280002642 | 1.65 | 85.5 | Neo-adjuvant (N) | 2016-08-30 | 2016-09-01 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025742 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003549 | 280002643 | 1.67 | 81.5 | Neo-adjuvant (N) | 2016-04-29 | 2016-05-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025744 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003550 | 280002644 | 1.73 | 57 | Curative (C) | null | 2014-03-01 | CETUXIMAB + RT | N | Y | 280025746 | CETUXIMAB + RT |
| 280003551 | 280002645 | 1.53 | 93.3 | Curative (C) | null | 2017-05-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 280025749 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003552 | 280002645 | 1.71 | 96.6 | Curative (C) | 2017-12-23 | 2017-12-31 | Cetuximab + Radiotherapy Load | 02 | Y | 280025749 | CETUXIMAB + RT |
| 280003553 | 280002646 | 1.7 | 126.5 | null | 2014-08-19 | 2014-08-19 | CETUXIMAB + RT | N | N | 280025754 | CETUXIMAB + RT |
| 280003554 | 280007329 | 1.78 | 67.3 | Palliative (P) | 2017-01-31 | 2017-02-11 | Doxorubicin + Ifosfamide | N | N | 280025755 | DOXORUBICIN + IFOSFAMIDE |
| 280003555 | 280002647 | 1.76 | 148 | Curative (C) | 2017-08-01 | 2017-08-14 | CETUXIMAB + RT | N | Y | 280025756 | CETUXIMAB + RT |
| 280003556 | 280002648 | 1.7 | 64.2 | null | 2014-11-03 | 2014-11-06 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025757 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003557 | 280002649 | 1.67 | 115 | Palliative (P) | 2014-11-25 | 2014-11-26 | Doxorubicin + Ifosfamide | 02 | N | 280025758 | DOXORUBICIN + IFOSFAMIDE |
| 280003558 | 280002650 | 1.78 | 72 | Not known (9) | 2017-10-29 | 2017-10-29 | CETUXIMAB + RT | 02 | Y | 280025761 | CETUXIMAB + RT |
| 280003559 | 280002651 | 1.7 | 64.6 | Curative (C) | 2017-02-01 | 2017-02-15 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280025762 | DOXORUBICIN + IFOSFAMIDE |
| 280003560 | 280002652 | 1.75 | 36.7 | Neo-adjuvant (N) | 2015-05-29 | 2015-06-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025763 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003561 | 280007330 | null | 81.5 | Palliative (P) | 2015-12-14 | 2016-01-02 | Doxorubicin + Ifosfamide | N | N | 280025764 | DOXORUBICIN + IFOSFAMIDE |
| 280003562 | 280007330 | 1.75 | 85.5 | Curative (C) | 2015-04-09 | 2015-05-14 | Cetuximab + Radiotherapy Load | N | Y | 280025764 | CETUXIMAB + RT |
| 280003563 | 280007330 | 1.79 | 73.6 | Neo-adjuvant (N) | null | 2018-01-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025764 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003564 | 280002653 | 1.55 | 94 | Curative (C) | 2016-08-04 | 2016-08-22 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025770 | CISPLATIN + FLUOROURACIL |